Lonetti, A.; Cappellini, A.; Bertaina, A.; Locatelli, F.; Pession, A.; Buontempo, F.; Evangelisti, C.; Evangelisti, C.; Orsini, E.; Zambonin, L.; Neri, L.M.; Martelli, A.M.; Chiarini, F., Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway., «JOURNAL OF HEMATOLOGY & ONCOLOGY», 2016, 9, Article number: 114, pp. 1 - 16 [articolo]Open Access
Buontempo, F; Orsini, E; Lonetti, A; Cappellini, A; Chiarini, F; Evangelisti, C; Evangelisti, C; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Bertacchini, J; Neri, Lm; Mccubrey, Ja; Martelli, Am., Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB., «ONCOTARGET», 2016, 7, pp. 1323 - 1340 [articolo]Open Access
Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buontempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli, PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors., «ONCOTARGET», 2015, 6, pp. 10399 - 10414 [articolo]Open Access
Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiarini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am, A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES, in: Vol 99, Issue supplement 2, «HAEMATOLOGICA», 2014, 99, pp. 62 - 62 (atti di: XIII Congress of the Italian Society of Experimental Hematology, Rimini, Italy, October 15–17, 2014) [atti di convegno-abstract]
Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C;
Chiarini F; Spartà AM; Bressanin D; Evangelisti C; Martelli AM, A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2)
INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC
LEUKEMIA (ALL) CELL LINES, in: Haematologica, «HAEMATOLOGICA», 2014, pp. 82 - 82 (atti di: XIII Congresso della Società italiana di Ematologia Sperimentale, Rimini, 15-17 October 2014) [atti di convegno-poster]
Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Bressanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am, ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS, in: Vol 99, Issue supplement 2, «HAEMATOLOGICA», 2014, 99, pp. 83 - 83 (atti di: XIII Congress of the Italian Society of Experimental Hematology, Rimini, Italy, October 15–17, 2014) [atti di convegno-abstract]
Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A;
Chiarini F; Buontempo F; Bressanin D; Lonetti A; Spartà A;
Bittman R; Pyne S; Pyne N; Martelli AM, ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS,
UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC
LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS, in: Haematologica, «HAEMATOLOGICA», 2014, pp. 83 - 83 (atti di: XIII Congresso della Società Italiana di Ematologia Sperimentale, Rimini, 15-18 October 2014) [atti di convegno-poster]
F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli., Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling, «LEUKEMIA», 2014, 28, pp. 543 - 553 [articolo]
Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; Cocco L, 1; Finelli, C, DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES, in: Vol 99, Issue supplement 2, «HAEMATOLOGICA», 2014, 99, pp. 44 - 45 (atti di: XIII Congress of the Italian Society of Experimental Hematology, Rimini, Italy, October 15–17, 2014) [atti di convegno-abstract]
A Lonetti; A Cappellini; A Spartà; D Bressanin; F Buontempo; F Chiarini; C Evangelisti; E Orsini; A Martelli, INHIBITION OF CLASS I PHOSPHATIDYLINOSITOL 3-KINASES (PI3KS) ISOFORMS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL): WHICH IS THE BEST THERAPEUTIC STRATEGY?, in: Vol 99, Issue supplement 1, «HAEMATOLOGICA», 2014, pp. 274 - 274 (atti di: 19th Congress of the European Hematology Association, Milano, June 12–15, 2014) [atti di convegno-abstract]
Lonetti A; Cappellini A; Spartà AM; Bressanin D; Buontempo F;
Chiarini F; Evangelisti C; Evangelisti C; Orsini E; Martelli AM, INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC
LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS, in: Haematologica, «HAEMATOLOGICA», 2014, 99, pp. 30 - 30 (atti di: XIII Congresso della Società italiana di Ematologia Sperimentale, Rimini, 15-17 October 2014) [atti di convegno-abstract]
Follo, My; Mongiorgi, S; Clissa, C; Poli, A; Lonetti, A; Stanzani, M; Cappellini, A; Billi, Am; Manzoli, L; Cocco, L; Finelli, C, SELECTIVE EFFECT OF LENALIDOMIDE ON CELL CYCLE AND INOSITIDE-DEPENDENT ERYTHROID SIGNALLING IN DEL(5Q) CELLS AND MYELODYSPLASTIC SYNDROMES (MDS), in: supplement 1, 2014, Vol 99, Issue supplement 1, pp. 85 - 85 (atti di: 19th Congress of the European Hematology Association, Milan, Italy, June 12–15, 2014) [atti di convegno-abstract]
A.M. Martelli; A. Lonetti; F. Buontempo; F. Ricci; P.L. Tazzari; C. Evangelisti; D. Bressanin; A. Cappellini; E. Orsini; F. Chiarini., Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells., «ADVANCES IN BIOLOGICAL REGULATION», 2014, 56, pp. 6 - 21 [articolo]
Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli., Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia, «INTERNATIONAL JOURNAL OF ONCOLOGY», 2014, 45, pp. 909 - 918 [articolo]
A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli., Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia., «CELL CYCLE», 2014, 13, pp. 2237 - 2247 [articolo]
